Shareholders have voted for the exit of Samarkand Group (LON: SMK) from Aquis and that will happen on 7 May. The share price recovered 573% to 0.505p, but it is still around 15% of the level before the plans to leave Aquis were revealed.
Hot Rocks Investments (LON: HRIP) is 44.4% ahead at 0.325p after it bought 40 million shares in Wishbone Gold (LON: WSBN) to 3.2%. Wishbone Gold has appointed Apex Geoscience to manage exploration and drilling programme at Red Setter Dome in Western Australia. This will accelerate the progress. Wishbone Gold shares rose 40.7% to 0.19p.
Walls and Futures REIT (LON: WAFR) wants to withdraw from Aquis and re-register as a private limited company. This will require shareholder approval and means that REIT status will be lost. It has been difficult to raise significant funds, and the market capitalisation is well below NAV. Malcolm Jordan and Ventura Finance have requisitioned a general meeting to appoint Ventura Finance controlling shareholder Mark Jackson to the company’s board. They also want to remove chief executive Joseph Taggart, who increased his stake to 3.35%. They also want a vote to remain on Aquis. There is likely to be one meeting for all the resolutions. The share price is one-third ahead at 20p.
BWA (LON: BWAP) chairman Jonathan Wearing bought 400,000 shares at 0.23p/share, taking his stake to 25.9% and managing director James Butterfield acquired 652,173 shares at 0.23p/share, taking his shareholding to 6.82%. The share price increased 14.3% to 0.2p.
Lift Global Ventures (LON: LFT) has extended the redemption date of its loan to Trans-Africa Energy to 30 May 2025. A Southern African state investor is awaiting approvals to provide funding. The share price firmed 10% to 0.275p.
KR1 (LON: KR1) had net assets of 52.16p/share at the end of March 2025, down from 58.2p/share one month earlier. There was aggregate income of £483,421 from staking activities. The share price improved 6.06% to 35p.
FALLERS
Kasei Digital Assets (LON: KASH) increased its NAV from £3.58m to £4.83m in the six months to January 2025. Disposals of assets have increased cash from £245,000 to £865,000. The company has undertaken a strategic review and decided that because the company is small it is best to seek shareholder approval for winding up the company. The target is to complete the disposal of assets and the winding up by the end of September 2025. The share price slipped 20.8% to 10.5p, compared with net assets of 14.5p/share before any requirement for tax on disposal gains.
Ananda Pharma (LON: ANA) says its phase 1 clinical trial to prove the safety and tolerability of MRX1 in healthy adults has been acknowledged by the Therapeutic Goods Administration in Australia under the Clinical Trial Notification scheme. The share price fell 11.8% to 0.375p.
Coinsilium (LON: COIN) says Bitcoin treasury strategy subsidiary Forza (Gibraltar) is developing internal systems and procedures. This should position it ahead of rivals. Coinsilium is trying to increase its profile in the US. The share price dipped 9.33% to 3.4p.
ChallengerX has completed the changing of its name to NYCE International (LON: NYCE). Management accounts for the first quarter of 2025 show revenues of £15,000. Net assets were £2.44m, or £600,000 excluding goodwill. The share price declined 3.03% to 0.16p.